190 related articles for article (PubMed ID: 28695525)
1. Purification of DNA Damage-Dependent PARPs from E. coli for Structural and Biochemical Analysis.
Langelier MF; Steffen JD; Riccio AA; McCauley M; Pascal JM
Methods Mol Biol; 2017; 1608():431-444. PubMed ID: 28695525
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
[TBL] [Abstract][Full Text] [Related]
3. Purification of human PARP-1 and PARP-1 domains from Escherichia coli for structural and biochemical analysis.
Langelier MF; Planck JL; Servent KM; Pascal JM
Methods Mol Biol; 2011; 780():209-26. PubMed ID: 21870263
[TBL] [Abstract][Full Text] [Related]
4. PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage.
Riccio AA; Cingolani G; Pascal JM
Nucleic Acids Res; 2016 Feb; 44(4):1691-702. PubMed ID: 26704974
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-Ribose) Polymerases: New Players in the Pathogenesis of Exocrine Pancreatic Diseases.
Martínez-Bosch N; Fernández-Zapico ME; Navarro P; Yélamos J
Am J Pathol; 2016 Feb; 186(2):234-41. PubMed ID: 26687988
[TBL] [Abstract][Full Text] [Related]
6. Mitotic functions of poly(ADP-ribose) polymerases.
Slade D
Biochem Pharmacol; 2019 Sep; 167():33-43. PubMed ID: 30910692
[TBL] [Abstract][Full Text] [Related]
7. Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers.
Przybycinski J; Nalewajska M; Marchelek-Mysliwiec M; Dziedziejko V; Pawlik A
Expert Opin Ther Targets; 2019 Sep; 23(9):773-785. PubMed ID: 31394942
[No Abstract] [Full Text] [Related]
8. Purification of Recombinant Human PARP-3.
Amé JC; Camuzeaux B; Dantzer F; Schreiber V
Methods Mol Biol; 2017; 1608():373-394. PubMed ID: 28695522
[TBL] [Abstract][Full Text] [Related]
9. Quantification of PARP Activity in Human Tissues: Ex Vivo Assays in Blood Cells and Immunohistochemistry in Human Biopsies.
Horvath EM; Zsengellér ZK; Szabo C
Methods Mol Biol; 2017; 1608():19-26. PubMed ID: 28695500
[TBL] [Abstract][Full Text] [Related]
10. Cell Cycle Resolved Measurements of Poly(ADP-Ribose) Formation and DNA Damage Signaling by Quantitative Image-Based Cytometry.
Michelena J; Altmeyer M
Methods Mol Biol; 2017; 1608():57-68. PubMed ID: 28695503
[TBL] [Abstract][Full Text] [Related]
11. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs.
Gagné JP; Ethier C; Defoy D; Bourassa S; Langelier MF; Riccio AA; Pascal JM; Moon KM; Foster LJ; Ning Z; Figeys D; Droit A; Poirier GG
DNA Repair (Amst); 2015 Jun; 30():68-79. PubMed ID: 25800440
[TBL] [Abstract][Full Text] [Related]
12. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
13. Interaction of PARP-2 with DNA structures mimicking DNA repair intermediates and consequences on activity of base excision repair proteins.
Kutuzov MM; Khodyreva SN; Amé JC; Ilina ES; Sukhanova MV; Schreiber V; Lavrik OI
Biochimie; 2013 Jun; 95(6):1208-15. PubMed ID: 23357680
[TBL] [Abstract][Full Text] [Related]
14. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
Carter-O'Connell I; Cohen MS
Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237
[TBL] [Abstract][Full Text] [Related]
15. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
[TBL] [Abstract][Full Text] [Related]
16. PARPs and the DNA damage response.
Sousa FG; Matuo R; Soares DG; Escargueil AE; Henriques JA; Larsen AK; Saffi J
Carcinogenesis; 2012 Aug; 33(8):1433-40. PubMed ID: 22431722
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
Hopkins TA; Shi Y; Rodriguez LE; Solomon LR; Donawho CK; DiGiammarino EL; Panchal SC; Wilsbacher JL; Gao W; Olson AM; Stolarik DF; Osterling DJ; Johnson EF; Maag D
Mol Cancer Res; 2015 Nov; 13(11):1465-77. PubMed ID: 26217019
[TBL] [Abstract][Full Text] [Related]
18. Using Clickable NAD
Zhang L; Lin H
Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
[TBL] [Abstract][Full Text] [Related]
20. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
